William A. Weiss

36.2k total citations · 8 hit papers
268 papers, 15.3k citations indexed

About

William A. Weiss is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, William A. Weiss has authored 268 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 64 papers in Pulmonary and Respiratory Medicine and 52 papers in Genetics. Recurrent topics in William A. Weiss's work include Glioma Diagnosis and Treatment (47 papers), Neuroblastoma Research and Treatments (39 papers) and Lung Cancer Diagnosis and Treatment (23 papers). William A. Weiss is often cited by papers focused on Glioma Diagnosis and Treatment (47 papers), Neuroblastoma Research and Treatments (39 papers) and Lung Cancer Diagnosis and Treatment (23 papers). William A. Weiss collaborates with scholars based in United States, Canada and United Kingdom. William A. Weiss's co-authors include Qi-Wen Fan, Kevan M. Shokat, Miller Huang, Katherine K. Matthay, Zachary A. Knight, W. Clay Gustafson, David Goldenberg, David Stokoe, C. David James and John M. Maris and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

William A. Weiss

261 papers receiving 14.8k citations

Hit Papers

A Pharmacological Map of the PI3-K Family Defines a Role ... 1997 2026 2006 2016 2006 2016 2008 2011 1997 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
    2006 940 citations Zachary A. Knight, David Goldenberg et al. profile →
  2. Neuroblastoma
    2016 897 citations Katherine K. Matthay, William A. Weiss et al. profile →
  3. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
    2008 781 citations Claudia Petritsch, Anders I. Persson et al. profile →
  4. Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
    2011 728 citations William A. Weiss et al. Clinical Cancer Research profile →
  5. Targeted expression of MYCN causes neuroblastoma in transgenic mice
    1997 595 citations William A. Weiss profile →
  6. Neuroblastoma and MYCN
    2013 469 citations William A. Weiss et al. profile →
  7. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
    2018 459 citations Zhenyi An, Qi-Wen Fan et al. profile →
  8. Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
    2013 457 citations Alexandre Puissant, Stacey M. Frumm et al. Cancer Discovery profile →

Peers

William A. Weiss
Mark W. Kieran United States
Richard J. Gilbertson United States
Zhengping Zhuang United States
W.K. Alfred Yung United States
Akira Nakagawara Japan
C. Patrick Reynolds United States
Andrew D.J. Pearson United Kingdom
Christel Herold‐Mende Germany
Nai‐Kong V. Cheung United States
Victor A. Levin United States
Mark W. Kieran United States
William A. Weiss
Citations per year, relative to William A. Weiss William A. Weiss (= 1×) peers Mark W. Kieran

Countries citing papers authored by William A. Weiss

Since Specialization
Citations

This map shows the geographic impact of William A. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Weiss more than expected).

Fields of papers citing papers by William A. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Weiss. The network helps show where William A. Weiss may publish in the future.

Co-authorship network of co-authors of William A. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Weiss. A scholar is included among the top collaborators of William A. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Weiss. William A. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schmidt, Christin, Sarah L. Cohen, Brian Gudenas, et al.. (2024). PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression. Scientific Reports. 14(1). 16074–16074. 5 indexed citations
3.
Silginer, Manuela, et al.. (2020). Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation. Molecular Cancer Therapeutics. 19(6). 1328–1339. 23 indexed citations
4.
Wong, Robyn A., Zhenyi An, Daphne A. Haas‐Kogan, et al.. (2019). Cooperative Blockade of PKCα and JAK2 Drives Apoptosis in Glioblastoma. Cancer Research. 80(4). 709–718. 17 indexed citations
5.
Rodríguez‐Blanco, Jezabel, Bin Li, Jun Long, et al.. (2018). A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma. Clinical Cancer Research. 25(4). 1379–1388. 24 indexed citations
6.
An, Zhenyi, et al.. (2018). EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Research. 78(24). 6785–6794. 50 indexed citations
7.
Pal, Sharmistha, David Kozono, Xiaodong Yang, et al.. (2018). Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas. Cancer Research. 78(14). 4007–4021. 71 indexed citations
8.
Olow, Aleksandra, Sabine Mueller, Xiao-Dong Yang, et al.. (2016). BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas. Clinical Cancer Research. 22(21). 5312–5321. 33 indexed citations
9.
Chen, Justin, Christopher S. Hackett, Shile Zhang, et al.. (2015). The Genetics of Splicing in Neuroblastoma. Cancer Discovery. 5(4). 380–395. 13 indexed citations
10.
Lau, Jasmine, Shirin Ilkhanizadeh, Susan Wang, et al.. (2015). STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma. Cancer Research. 75(20). 4302–4311. 67 indexed citations
11.
Maly, Dustin J., Yvan H. Chanthery, Daniel W. Sirkis, et al.. (2014). Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma. Molecular Cancer Therapeutics. 14(2). 419–428. 23 indexed citations
12.
Teitz, Tal, Marcus B. Valentine, Kejin Zhu, et al.. (2013). Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis. Cancer Research. 73(13). 4086–4097. 48 indexed citations
13.
Puissant, Alexandre, Stacey M. Frumm, Gabriela Alexe, et al.. (2013). Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition. Cancer Discovery. 3(3). 308–323. 457 indexed citations breakdown →
14.
Barkovich, Krister J., Sujatmi Hariono, Adam L. Garske, et al.. (2012). Kinetics of Inhibitor Cycling Underlie Therapeutic Disparities between EGFR-Driven Lung and Brain Cancers. Cancer Discovery. 2(5). 450–457. 39 indexed citations
15.
More, Swati S., Melissa Itsara, Xiao-Dong Yang, et al.. (2011). Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems. Clinical Cancer Research. 17(8). 2339–2349. 51 indexed citations
16.
Nicolaides, Theodore, Huifang Li, David A. Solomon, et al.. (2011). Targeted Therapy for BRAFV600E Malignant Astrocytoma. Clinical Cancer Research. 17(24). 7595–7604. 113 indexed citations
17.
Collier, Lara S., David J. Adams, Christopher S. Hackett, et al.. (2009). Whole-Body Sleeping Beauty Mutagenesis Can Cause Penetrant Leukemia/Lymphoma and Rare High-Grade Glioma without Associated Embryonic Lethality. Cancer Research. 69(21). 8429–8437. 59 indexed citations
18.
Fan, Qi-Wen, Christine Cheng, Theodore Nicolaides, et al.. (2007). A Dual Phosphoinositide-3-Kinase α/mTOR Inhibitor Cooperates with Blockade of Epidermal Growth Factor Receptor in PTEN -Mutant Glioma. Cancer Research. 67(17). 7960–7965. 160 indexed citations
19.
Chesler, Louis, David Goldenberg, Ronit Satchi‐Fainaro, et al.. (2007). Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma. Cancer Research. 67(19). 9435–9442. 54 indexed citations
20.
Hong, Chibo, Alika K. Maunakea, Peter Jun, et al.. (2005). Shared Epigenetic Mechanisms in Human and Mouse Gliomas Inactivate Expression of the Growth Suppressor SLC5A8. Cancer Research. 65(9). 3617–3623. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark W. Kieran Breakdown of academic impact, for papers by Richard J. Gilbertson Breakdown of academic impact, for papers by Zhengping Zhuang Breakdown of academic impact, for papers by W.K. Alfred Yung Breakdown of academic impact, for papers by Akira Nakagawara Breakdown of academic impact, for papers by C. Patrick Reynolds Breakdown of academic impact, for papers by Andrew D.J. Pearson Breakdown of academic impact, for papers by Christel Herold‐Mende Breakdown of academic impact, for papers by Nai‐Kong V. Cheung Breakdown of academic impact, for papers by Victor A. Levin
Rankless by CCL
2026